Bromocriptine as a Potential Glucose-lowering Agent for the Treatment of Prolactinoma with Type 2 Diabetes. Oshige T, Nakamura Y, Sasaki Y, Kawano S, et al. Intern Med 2019;58:3125-3128.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Oshige T, Nakamura Y, Sasaki Y, Kawano S, et al. Bromocriptine as a Potential Glucose-lowering Agent for the Treatment of Prolactinoma with Type 2 Diabetes. Intern Med 2019;58:3125-3128.
PMID: 31243214